ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

A Single-Center Analysis of Using Allele-Level 11 HLA Loci Information on cPRA and Organ-Allocation Points in Kidney Transplant Candidates

C. Maguire1, P. Muluhngwi1, E. Kransdorf2, L. Gragert3, A. R. Tambur1

1Northwestern University, Chicago, IL, 2Cedars-Sinai Heart Institute, Beverly Hills, CA, 3Tulane University, New Orleans, LA

Meeting: 2020 American Transplant Congress

Abstract number: 18

Keywords: Allocation, HLA antibodies, Kidney transplantation, Panel reactive antibodies

Session Information

Date: Saturday, May 30, 2020

Session Name: Kidney Deceased Donor Allocation I

Session Time: 3:15pm-4:45pm

 Presentation Time: 4:27pm-4:39pm

Location: Virtual

Related Abstracts
  • A Calculated Panel Reactive Antibody (CPRA) Calculator Supporting Both Allele-Level and Antigen-Level HLA Specificities
  • CPRA Values Are Substantially Increased for Some Candidates Subsequent to Inclusion of Unacceptable C-locus (UA-C) Antigens While Listing Practices Remain Unchanged

*Purpose: Calculated panel reactive antibodies (cPRA) is used by the United Network for Organ Sharing (UNOS) to quantify degree of HLA sensitization and assign priority in organ allocation. The current calculator relies heavily on low-resolution unacceptable antigen (UA) assignment and disregards the DQA, DPA, and DPB loci. We calculated cPRA based on 11-locus high-resolution genotype frequency data from the National Marrow Donor Program (NMDP), and compared it with the standard UNOS cPRA to determine whether it would change assigned allocation points in a cohort of active waitlist patients at our center.

*Methods: NMDP calculator: http://transplanttoolbox.org/nmdp_cpra/

Antibody specificities from single antigen bead assays on 420 consecutive active waitlist transplant candidates were used to compute UNOS and NMDP cPRA values. All positively reacting beads from the most recent assay were considered UAs, and were entered into the UNOS calculator at antigen-level and into the NMDP calculator at two-field allele-level with DQ and DP entered as alpha/beta combinations. Allocation points were determined based on the current UNOS KAS sliding scale.

*Results: 214/420 patients exhibited HLA antibodies, and thus were impacted by changing calculators. In most cases, the NMDP analysis resulted in lower cPRAs and allocation points. Patients in the 50-79% UNOS cPRA group showed the most cPRA variation, while allocation points varied the most within the highest cPRA groups (Figure 1). Importantly, 10/35 patients assigned to the 100% UNOS cPRA group dropped to a lower cPRA group using the allelic calculator, with 5/10 dropping 2 or more groups. 8/10 were primarily due to the use of HLA-DQ alpha/beta allelic combinations rather than antigen. Inclusion of DP had a varying effect on NMDP calculations.

*Conclusions: The use of allele-level UAs and inclusion of all HLA loci in cPRA calculation resulted in prominent changes to the allocation points assigned to current waitlist patients, particularly those that are highly sensitized. Currently, it is possible to assign UAs at the allele level; however, the UNOS calculator does not translate this into changes in cPRA nor in allocation points. Capturing the true level of HLA sensitization is critical, as minor decreases in cPRA at the highest end translate into significant increases to the pool of compatible donors. Our data suggest that some patients may be unjustly prioritized within the allocation system while missing on potential donors.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Maguire C, Muluhngwi P, Kransdorf E, Gragert L, Tambur AR. A Single-Center Analysis of Using Allele-Level 11 HLA Loci Information on cPRA and Organ-Allocation Points in Kidney Transplant Candidates [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/a-single-center-analysis-of-using-allele-level-11-hla-loci-information-on-cpra-and-organ-allocation-points-in-kidney-transplant-candidates/. Accessed February 28, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.